177 related articles for article (PubMed ID: 27023146)
21. Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing.
Li W; Qiu T; Guo L; Ying J
Cancer Lett; 2017 Dec; 410():92-99. PubMed ID: 28942013
[TBL] [Abstract][Full Text] [Related]
22. Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis.
Crona J; Backman S; Maharjan R; Mayrhofer M; Stålberg P; Isaksson A; Hellman P; Björklund P
Clin Cancer Res; 2015 Oct; 21(19):4451-60. PubMed ID: 25991818
[TBL] [Abstract][Full Text] [Related]
23. Frameshift mutations in mammalian target of rapamycin pathway genes and their regional heterogeneity in sporadic colorectal cancers.
Choi MR; Yoo NJ; An CH; Lee SH
Hum Pathol; 2015 May; 46(5):753-60. PubMed ID: 25776026
[TBL] [Abstract][Full Text] [Related]
24. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
[TBL] [Abstract][Full Text] [Related]
25. Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer.
Liu M; Liu Y; Di J; Su Z; Yang H; Jiang B; Wang Z; Zhuang M; Bai F; Su X
BMC Cancer; 2017 Nov; 17(1):787. PubMed ID: 29169336
[TBL] [Abstract][Full Text] [Related]
26. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
[No Abstract] [Full Text] [Related]
27. Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors.
Saber A; Hiltermann TJN; Kok K; Terpstra MM; de Lange K; Timens W; Groen HJM; van den Berg A
Carcinogenesis; 2017 Feb; 38(2):144-151. PubMed ID: 27993895
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
[TBL] [Abstract][Full Text] [Related]
29. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
[TBL] [Abstract][Full Text] [Related]
30. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
Berg KCG; Eide PW; Eilertsen IA; Johannessen B; Bruun J; Danielsen SA; Bjørnslett M; Meza-Zepeda LA; Eknæs M; Lind GE; Myklebost O; Skotheim RI; Sveen A; Lothe RA
Mol Cancer; 2017 Jul; 16(1):116. PubMed ID: 28683746
[TBL] [Abstract][Full Text] [Related]
31. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
[TBL] [Abstract][Full Text] [Related]
32. Frameshift mutations of OGDH, PPAT and PCCA genes in gastric and colorectal cancers.
Jo YS; Oh HR; Kim MS; Yoo NJ; Lee SH
Neoplasma; 2016; 63(5):681-6. PubMed ID: 27468871
[TBL] [Abstract][Full Text] [Related]
33. Proteome Heterogeneity in Colorectal Cancer.
Lim LC; Lim YM
Proteomics; 2018 Feb; 18(3-4):. PubMed ID: 29316255
[TBL] [Abstract][Full Text] [Related]
34. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
[TBL] [Abstract][Full Text] [Related]
35. Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets.
Chen C; Liu S; Qu R; Li B
Biomed Res Int; 2020; 2020():2861240. PubMed ID: 32733937
[TBL] [Abstract][Full Text] [Related]
36. The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing.
Zou SM; Li WH; Wang WM; Li WB; Shi SS; Ying JM; Lyu N
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2149-2159. PubMed ID: 30171333
[TBL] [Abstract][Full Text] [Related]
37. TP53 mutation is enriched in colorectal cancer liver metastasis in the context of polyclonal seeding.
Sun W; Sun Q; Zhong A; Lyne AM; Huang D; Han F; Lai M; Zhang H
Pathol Res Pract; 2022 Aug; 236():153958. PubMed ID: 35679752
[TBL] [Abstract][Full Text] [Related]
38. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
39. Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers.
Oh HR; An CH; Yoo NJ; Lee SH
Pathol Oncol Res; 2015 Jul; 21(3):713-8. PubMed ID: 25573589
[TBL] [Abstract][Full Text] [Related]
40. Intratumor Heterogeneity of KRAS Mutation Status in Pancreatic Ductal Adenocarcinoma Is Associated With Smaller Lesions.
Nagawkar SS; Abu-Funni S; Simon E; Bick T; Prinz E; Sabo E; Ben-Izhak O; Hershkovitz D
Pancreas; 2016 Jul; 45(6):876-81. PubMed ID: 26646269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
